ESC Professional Premium Access

Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Event: ESC Congress 2022
Topic: Treatment
Session type: Official Joint Session
Date: 27 August 2022
Time: 16:30 - 17:30

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

What is ATTR cardiac amyloidosis and how is it diagnosed?

Speaker: Doctor M. Corneli (Capital Federal, AR)
Thumbnail

How should ATTR cardiac amyloidosis cardiomyopathy be treated?

Speaker: Professor T. Damy (Creteil, FR)
Thumbnail

How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?

Speaker: Doctor T. Treibel (London, GB)
Thumbnail

Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.

Thumbnail

3 speakers from this session

Doctor Mariana Corneli

Instituto Cardiovascular de Buenos Aires, Capital Federal (Argentina)
1 presentation
0 follower

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)
21 presentations
0 follower

Doctor Thomas Treibel

Barts Heart Centre and University College London, London (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk